Comparison of Screening Tools for Sarcopenia in Older Patients With Type 2 Diabetes Mellitus
Western Journal of Nursing Research · 2025
DOI: 10.1177/01939459251332244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Western Journal of Nursing Research, 2025. Verfasst von Rui Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: General Thoracic Surgery, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Sarcopenia, Diabetes Mellitus, Type 2, Mass Screening. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Hospital Research Fund for Nursing of Affiliated Zhongshan Hospital of Dalian University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The prevalence of sarcopenia is high in older patients with type 2 diabetes mellitus (T2DM).
Objectives
We evaluated the accuracy of the Strength, Assistance in Walking, Rise from a Chair, Climb Stairs, and Falls (SARC-F) questionnaire, the SARC-F combined with the Calf Circumference (SARC-CalF) questionnaire, the SARC-F incorporating Elderly and Body Mass Index Information (SARC-F+EBM) questionnaire, the MiniSarcopenia Risk Assessment 5-item (MSRA-5) questionnaire, the MiniSarcopenia Risk Assessment 7-item (MSRA-7) questionnaire, and the Ishii test score (Ishii) as screening tools for sarcopenia in older patients with T2DM.
Methods
Patients with T2DM aged 60 years and older were enrolled. The Asian Working Group for Sarcopenia 2019 diagnostic criteria were used to determine the presence of sarcopenia in patients. The accuracy of the 6 screening methods was assessed using sensitivity, specificity, and area under the receiver operating characteristic curve (AUC).
Results
In total, 225 older patients (111 men; 114 women) with T2DM participated in the study. The overall prevalence of sarcopenia was 24%, with 34.23% in men and 14.04% in women. Among all participants, the sensitivity of the 6 screening tools for sarcopenia was 18.52% to 92.59%, the specificity was 31.58% to 92.98%, and the AUC was 0.588 to 0.863. Among the 6 screening tools, the Ishii test has the highest AUC for screening both men and women, and its sensitivity and specificity are relatively balanced, both above 75%.
Conclusions
Of the 6 screening tools, the Ishii test proved to be the most suitable for early sarcopenia screening within this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Thoracic Surgery, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
- School of Nursing, Dalian University, Dalian, Liaoning, China.
- Department of Metabolic Nutrition, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
- Department of Nursing, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
ORCID-Profile: Rui Zhang
Förderung
- Hospital Research Fund for Nursing of Affiliated Zhongshan Hospital of Dalian University
Zitieren
APA
Zhang, R., Wang, Y., Liu, Y., Chen, L., & Ji, D. (2025). Comparison of Screening Tools for Sarcopenia in Older Patients With Type 2 Diabetes Mellitus. Western Journal of Nursing Research. https://doi.org/10.1177/01939459251332244
Vancouver
Zhang R, Wang Y, Liu Y, Chen L, Ji D. Comparison of Screening Tools for Sarcopenia in Older Patients With Type 2 Diabetes Mellitus. Western Journal of Nursing Research. 2025. doi:10.1177/01939459251332244
BibTeX
@article{Zhang2025,
author = {Zhang, Rui and Wang, Yao and Liu, Yazhuo and Chen, Lixia and Ji, Daihong},
title = {Comparison of Screening Tools for Sarcopenia in Older Patients With Type 2 Diabetes Mellitus},
journal = {Western Journal of Nursing Research},
year = {2025},
doi = {10.1177/01939459251332244}
}
EUVIMED